SignalMacro

REDHILL (RDHL) ACQUIRES REBYOTA AND CLENPIQ COMMERCIALIZATION RIGHTS FOR $12M UPFRONT. CAN SALES OUTPACE ROYALTIES? - YAHOO

Redhill's $12M upfront acquisition of Rebyota and Clenpiq commercialization rights raises sales-versus-royalty question.

What changed

Redhill's $12M upfront acquisition of Rebyota and Clenpiq commercialization rights raises sales-versus-royalty question.

Why it matters

Redhill's $12M upfront acquisition of Rebyota and Clenpiq commercialization rights raises sales-versus-royalty question. — impact context not separately stored; see What changed.

Sources

yahoo